parallel sessions - International Society for Blood Transfusion

PostersISBT2006PostersTOPIC 01.5The posters areon display fromMonday - ThursdayTOPIC 01.6The posters areon display fromMonday - ThursdayP-096 RESULTS OF NAT- AND ANTIBODY-SCREENING FOR WEST NILEVIRUS IN GERMANY AND AUSTRIAM.K. Hourfar, C. Pfleiderer, J. Eckert, A. Themann, E. Seifried, M. Nuebling, M. Schmidt(German Red Cross, Institute Frankfurt, Frankfurt, Germany)P-104 INACTIVATION OF CHIKUNGUNYA VIRUS IN PLASMA AND PLATELETSUSING HELINX TECHNOLOGY, AS UTILIZED IN THE INTERCEPT BLOODSYSTEML. Corash, L. Sawyer, K. Dupuis, A. Sampson-Johannes, T. Dubensky, D.L. Vanlandingham,K. Tsetsarkin, S. Higgs (Cerus Corporation, Concord, United States of America)P-097 PROTECTIVE ROLE OF NATURAL ANTIBODIES IN WNV INFECTION:IN VITRO INFECTIVITY OF WNV ID NAT REACTIVE PLASMAS CONTAININGSPECIFIC ANTIBODIES (IGM AND/OR IGG)M. Rios, S. Daniel, S.L. Stramer, S. Caglioti, O. Wood, I.K. Hewlett (CBER/FDA, Bethesda,United States of America)Topic 01.6.Blood Safety - TTD - Nucleic Acid Amplification Technology (NAT)P-098 YIELD OF MINIPOOL AND INDIVIDUAL DONATION NUCLEIC ACIDAMPLIFICATION TESTING FOR WEST NILE VIRUS RNA IN UNITED STATESBLOOD DONORS, 2003-2005L. Stramer, G.A. Foster, J.P. Brodsky, S.G. Caglioti, D.M. Strong (American Red Cross,Gaithersburg, United States of America)P-105 THE CONTRIBUTION OF NUCLEID ACID TESTING (NAT) IN BLOODTRANSFUSION SAFETY. DETECTION OF FOUR NAT HBV DNA POSITIVE,HBS AG NEGATIVE IN SINGLE BLOOD DONATIONSC. Politi, V. Dimitra, L. Kavallierou, V. Triantaltillou, (G.Gennimatas Hospital, Athens, Greece)80Topic 01.5.Blood Safety - TTD - Emerging PathogensP-106 IMPLEMENTATION OF A POST-DONATION TRIPLEX HIV/HBV/HCVNAT IN A TEACHING HOSPITAL TRANSFUSION MEDICINE UNIT INKUMASI, GHANAJ.P. Allain, S. Owusu-Ofori, G. Bedu-Addo, D. Candotti, A. Nsiah-Asare, F. Sarkodie(University of Cambridge, Cambridge, United Kingdom)81P-100 IMMUNOGLOBULIN G ANTIBODIES AGAINST ENVIRONMENTALMOULDS IN A NORWEGIAN HEALTHY POPULATION SHOWS A BIMODALDISTRIBUTION FOR ASPERGILLUS VERSICOLORG. Hetland, B. Rydjord, V. Svenningsen, H.G. Wiker (Ulleval University Hospital, Oslo, Norway)P-107 PREVALENCE OF HCV AND HGV INFECTION AMONG THALASSEMICS,HEMOPHILICS, AND HEMODIALYSIS PATIENTS WITH CHRONIC HEPATITISS. Amini Kafi-abad, A. Talebian, S. Samiee, F. Ranjbar Kermani, M.M. Moghtadaie,F. Ferdowsian, N.P. Pasandideh, Z. Ataie, M. Kavari, A. Gharehbaghian (Research Center ofIranian Blood Transfusion, Tehran, Iran)P-101 THE NEEDS OF LOOK BACK ON SCREENING OF HUMAN T CELLLYMPHOTROPIC VIRUS TYPE 1 AND 11 (HTLV I / II) AMONG BLOODDONORS IN SAUDI ARABIAS. ibrahim Hindawi, G.A. Damanhouri, I.S. Kawashti, I. Felemban, M. Alshawa, M. Khanbashi(KAUH, Jeddah, Saudi Arabia)P-108 HEAD TO HEAD COMPARISON OF TWO NEW AUTOMATED NATSYSTEMS CHIRON PROCLEIX TIGRIS SYSTEM VS ROCHE COBAS S 201A. Assal, V. Barlet, C. Cornillot, M. Deschazeaux, I. Dupont, P. Gallian, C. Guitton, P. Morel,G. Andreu (EFS Centre Atlantique, Tours, France)P-102 TRANSFUSION-TRANSMITTED HUMAN PARVOVIRUS B19 INFECTIONIN A THALASSAEMIA PATIENTSM. Mahmoodian Shooshtari, M. Nabi Foroghi, Z. Sharifi (Research Center of IBTO, Tehran, Iran)P-109 WINDOW PERIOD OF HIV INFECTION IN A REPEAT BLOOD DONORL. Barea, R. Gonzalez, J.l. Bueno, L. Muñoz, A. Garcia, E. Castro (Centro de Transfusión CruzRoja Española, Madrid, Spain)P-103 IN VITRO EVALUATION OF CELL-MEDIATED IMMUNITY TO EPSTEINBARR VIRUSM. Mahmoodian Shooshtari, M. Bani Talebi Dehkordi, Z. Sharifi (Research Center of IBTO,Tehran, Iran)P-110 SEROLOGICAL AND MOLECULAR CHARACTERISTICS OF HBV DNAPOSITIVE/ HBSAG NEGATIVE BLOOD DONORSE. Brojer, M. Letowska, G. Liszewski, P. Grabarczyk, M. Mikulska (Institute of Haematologyand Blood Transfusion, Warsaw, Poland)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT